195 related articles for article (PubMed ID: 6697321)
21. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
22. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives: III. Experimental antitumor activities of lactosaminated serum albumin conjugates.
Rao KS; Collard MP; Cornet J; Trouet A
Anticancer Res; 1989; 9(4):973-9. PubMed ID: 2510584
[TBL] [Abstract][Full Text] [Related]
23. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells.
Knick VC; Eberwein DJ; Miller CG
J Natl Cancer Inst; 1995 Jul; 87(14):1072-7. PubMed ID: 7616599
[TBL] [Abstract][Full Text] [Related]
24. Antitumour activity of some cyclophosphazenes.
Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
[No Abstract] [Full Text] [Related]
25. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
26. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
Mathé G; Reizenstein P
Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
[TBL] [Abstract][Full Text] [Related]
27. Vinorelbine: a novel vinca alkaloid.
Toso C; Lindley C
Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Atassi G; Berlion M; el Oche Y; Bizzari JP
Anticancer Res; 1991; 11(2):975-80. PubMed ID: 2064354
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
Conrad RA; Cullinan GJ; Gerzon K; Poore GA
J Med Chem; 1979 Apr; 22(4):391-400. PubMed ID: 430477
[TBL] [Abstract][Full Text] [Related]
30. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL
Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658
[TBL] [Abstract][Full Text] [Related]
31. Vinorelbine (Navelbine): a third-generation vinca alkaloid.
Budman DR
Cancer Invest; 1997; 15(5):475-90. PubMed ID: 9316630
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
Miller TP; Jones SE; Chester AB; Dorr RT
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
[No Abstract] [Full Text] [Related]
33. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
34. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
Chello PL; Sirotnak FM
Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
[TBL] [Abstract][Full Text] [Related]
35. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
36. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
37. [New antitumor derivatives of vinblastine].
Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
[TBL] [Abstract][Full Text] [Related]
38. Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.
Aggarwal A; Kruczynski A; Frankfurter A; Correia JJ; Lobert S
Invest New Drugs; 2008 Aug; 26(4):319-30. PubMed ID: 18071633
[TBL] [Abstract][Full Text] [Related]
39. Experimental antitumor activity of Navelbine.
Cros S; Wright M; Morimoto M; Lataste H; Couzinier JP; Krikorian A
Semin Oncol; 1989 Apr; 16(2 Suppl 4):15-20. PubMed ID: 2711203
[No Abstract] [Full Text] [Related]
40. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]